AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
VivoSim Labs, Inc. Common Stock
XNAS · usd
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG001V10TP9
0.15▼ 0.01 (-6.84%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
0.16
Day's Range
0.14 – 0.16
52-Week Range
0.14 – 4.46
Volume
744.6K
Avg Volume
961.1K
Share Statistics
Shares Outstanding
Employees
9
Exchange
XNAS
Listed
2011-08-16
Share count as of August 10, 2026

VivoSim Labs, Inc. Common Stock (VIVS) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about VivoSim Labs, Inc. Common Stock (VIVS)
What is VivoSim Labs, Inc. Common Stock's Market Cap?
VivoSim Labs, Inc. Common Stock's Market Cap is $2.2M, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's Enterprise Value?
VivoSim Labs, Inc. Common Stock's Enterprise Value is $535.3K, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's Price / Sales?
VivoSim Labs, Inc. Common Stock's Price / Sales is 19.7×, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's EV / Revenue?
VivoSim Labs, Inc. Common Stock's EV / Revenue is 4.8×, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's EV / EBITDA?
VivoSim Labs, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's Revenue (TTM)?
VivoSim Labs, Inc. Common Stock's Revenue (TTM) is $112.0K, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's Net Income (TTM)?
VivoSim Labs, Inc. Common Stock's Net Income (TTM) is -$12.3M, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's EBITDA?
VivoSim Labs, Inc. Common Stock's EBITDA is -$11.1M, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's Diluted EPS (TTM)?
VivoSim Labs, Inc. Common Stock's Diluted EPS (TTM) is -0.83, based on as-reported figures from SEC (XBRL) filings.
What is VivoSim Labs, Inc. Common Stock's EBITDA Margin?
VivoSim Labs, Inc. Common Stock's EBITDA Margin is -9943.8%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · VIVSAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues
Total Revenues
YoY growth-51.4%-21.6%+8.3%-6.7%
Research and development expenses
Selling, general and administrative expenses
Total costs and expenses
% of revenue15427.8%8067.5%10676.9%9510.7%
Loss from Operations
% of revenue-15327.8%-7967.5%-10576.9%-9410.7%
Other Income (Expense)
Gain on change in fair value of common stock warrant liabilities———
Interest income
Interest expense
Total Other Income
Income Tax Expense
Net Loss
% of revenue-7433.3%-14410.0%-10350.0%-9089.3%
Net loss per common share basic
Net loss per common share diluted